Background Although alcohol use disorder (AUD) is common in steatotic liver disease (SLD), its true prevalence is unknown ...
Autoimmune liver diseases (AILDs), including autoimmune hepatitis, primary biliary cholangitis, primary sclerosing ...
We read with interest the Rome Foundation paediatric global study by Nurko and colleagues,1 which establishes a multinational ...
Background The impact of circulating tumour DNA (ctDNA) detection, which informs minimal residual disease (MRD) after ...
Background Pain in chronic pancreatitis (CP) is multifactorial. Efficacy of pancreatic enzyme replacement therapy (PERT) for pain remains uncertain. Objective To assess the effect of ...
Background Hospitalisations represent major clinical events in cirrhosis, yet prediction based on clinical variables alone remains limited. Objective Given the role of the gut microbiome in disease ...
The recent conditional US Food and Drug Administration (FDA) approval of two therapies, resmetirom (Rezdiffra) and semaglutide (Wegovy), marks the first time clinicians have pharmacological therapy ...
5 State Key Laboratory of Multi-organ Injury Prevention and Treatment, Southern Medical University, Guangzhou, China 6 Guangdong Provincial Key Laboratory of Chinese Medicine Ingredients and Gut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results